Target, CVS and Rite Aid have removed items off the shelves following federal inspectors discovered unsanitary conditions and recommended recalls.
Health officials in the United States are encouraging users to refrain from taking more than two dozen of the over-the-counter eyedrops due to the possibility of an eye infection that could result in partial loss of sight or complete blindness.
The Food and Drug Administration issued an alert Friday that highlighted 26 products for eye care comprising gels and eyedrops made by CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up and Up, and Velocity Pharma.
The Federal Drug Administration has recommended that the manufacturer remove all batches of these products following agency investigations that revealed unhealthy conditions inside the manufacturing facility as per the news announcement from the F.D.A. Tests for bacterial infections came back positive in critical manufacturing areas within the plant that the agency could not identify immediately.
The F.D.A. stated that they had no reports of illness linked to these drugs; however, it was urging healthcare health professionals as well as individuals to notify any infections to the F.D.A.
The drugs must be sterilized, and the regulators stated that the drugs injected into the eyes stop some of the body's defences.
The F.D.A. advised that consumers take the proper steps to get rid of the products they purchase by taking the items to the drug disposal website or by examining whether the product is in the F.D.A.'s "flush list" of substances that could be safely removed at home.
CVS, Rite Aid and Target are taking the brands from their sites and stores, The agency announced. The products marketed as Leader Velocity, Rugby, and Leader might still be sold on the Internet and in retail stores but are not recommended for purchase according to federal regulators.
Rite Aid confirmed through a spokesperson that it had removed "applicable Rite Aid branded products" from its shelves. The CVS spokesperson said the retailer "immediately stopped the sale in-store and online of all products supplied by Velocity Pharma within the CVS Health Brand Eye Products portfolio," and customers can return items for a full refund. Other retailers waited to answer inquiries.
In the past, there have been several instances of eye-care products.
In January, the Centers for Disease Control and Prevention and the F.D.A. advised consumers not to use EzriCare Artificial Tears and Delsam Pharma's Artificial Tears. Eyedrops have been linked to a drug-resistant form of the bacteria Pseudomonas . The strain has been connected to four deaths and loss of vision in fourteen patients.
Apotex, a Canadian Pharmaceutical company, recalled prescription eyedrops in March because the caps of some bottles were cracked and could cause a compromise to the sterility of the product.
Specialists claim that eyedrops are secure to make use of. Between 2024 and 2024, more than more than 123 million Americans will be using eyedrops, according to Statista, which is a firm that conducts market research.